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ABSTRACT 
Objective: The objective of this investigation is to present the simple and sensitive method for the analysis of Telmisartan and Hydrochlorothiazide 
and apply the proposed method for the analysis of said drugs in pharmaceutical formulations. 
Methods: Telmisartan and Hydrochlorothiazide are used in combination for treatment of hypertension. The present work deals with simple 
derivative spectrophotometric method development for simultaneous estimation of Telmisartan and Hydrochlorothiazide in two component tablet 
formulation. 
Results: The method employed first order derivative spectroscopy for determination of ʎmax by taking 10 μg/ml each of Telmisartan and 
Hydrochlorothiazide were scanned in 200-400 nm range and ʎmax
Conclusion: For this method, linearity was observed in 2-40 μg/ml for Telmisartan and 2-20 μg/ml for Hydrochlorothiazide. The recovery study 
confirmed the accuracy of the proposed method and low values of standard deviation confirmed precision of the used method. The method was 
validated as per ICH guidelines. 
 were observed 291 nm for Telmisartan and Hydrochlorothiazide showed zero 
crossing point and 251 nm for Hydrochlorothiazide and Telmisartan showed zero crossing point in first order derivative spectroscopy. 




Telmisartan (fig. 1) is an angiotensin II receptor antagonist, used in 
the management of hypertension. Generally, angiotensin II receptor 
blockers such as telmisartan (telm) bind to the angiotensin II, type 1 
receptors with high affinity, causing inhibition of the action of 
angiotensin II on vascular smooth muscles, ultimately leading to a 
reduction in arterial blood pressure. 
A hydrochlorthiazide (HCTZ; fig. 2) diuretic often considered the 
prototypical member of this class. It reduces the reabsorption of 
electrolytes from the renal tubules. Thus results in increased 
excretion of water and electrolytes, including sodium, potassium, 
chloride, and magnesium. It has been used in the treatment of 
several disorders including edema, hypertension, diabetes insipidus, 
and hypoparathyroidism. 
MATERIALS AND METHODS 
Instruments  
A UV Probe type UV-VIS double beam spectrophotometer (Shimadzu 
1800) with 1 cm Quartz cells was used in this experiment. Analysis 
was performed using direct mode over a wavelength range from 
200–400 nm. The instrument settings were zero order and first 
derivative mode and band width of 2 nm in the range of 200-400 
nm. All weights were taken on electronic balance. 
Reagents and chemicals 
Telmisartan working standard was obtained as a gift sample from 
Lupin Research Park, Pune, India and HCTZ as a gift sample from 
CTX Life sceiences Pvt Ltd. Methanol (Spectrochem chemicals) and 
Telmisartan and Hydrochlorothiazide combination tablet (Telista-H) 






Fig. 1: Chemical structure of Telmisartan Fig. 2: Chemical structure of Hydrochlorthiazide 
  
Methodology (First order derivative method) 
Preparation of standard stock solutions 
10 mg each of the standard telm and HCTZ were weighed and 
transferred to two separate 100 mL volumetric flasks and dissolved 
in methanol (98% v/v) and further diluted with the methanol to get 
the standard solutions of telm and HCTZ 100 μg mL-1 of each. 
Further dilution was made to produce concentrations of 40 µg/ml 
for telm and 12.5 µg/ml for HCTZ. The dilutions of telm and HCTZ 
were prepared from this standard stock solution to get the 
concentrations in the range of 2-20 µg/ml. Each of the solutions was 
scanned between 200–400 nm at a medium scanning speed. All the 
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Zero order spectra were then converted to their respective first 
order derivative Spectra using the inbuilt software (Shimadzu UV 
probe 2.34) and zero crossing point (ZCP) of telm and HCTZ were 
found to be at 251 nm and 291 nm respectively. Responses of each 
of the above solutions were measured at 251 nm (ZCP of telm) and 
291 nm (ZCP of HCTZ). Lambert Beer’s curves were plotted for HCTZ 
and telm at 251 nm and 291 nm respectively. The straight line equations 
and correlation coefficients for telm and HCTZ were determined. 
 
 
Fig. 3: First order derivative spectra of HCTZ 
 
 
Fig. 4: First Order derivative spectra of Telmisartan 
 
Method validation 
Linearity and range (n = 6) 
The linearity response was determined by analyzing 6 independent 
levels of the calibration curve in the concentration range of 2-20 μg/ml 
(2, 4, 8, 12, 16, and 20 μg/ml) for telm and HCTZ. The calibration curve of 
responses against concentration was plotted. Correlation coefficient and 
regression line equations for telm and HCTZ were calculated. Linearity 
range was established through consideration of necessary practical 
range and according to each drug concentration present in the 
pharmaceutical product, to give accurate, precise and linear results. 
Accuracy (n = 3) 
It was carried out to determine the suitability and reliability of the 
proposed method. Accuracy was determined by calculating the % 
recovery of telm and HCTZ by the standard addition method, in 
which, the known amounts of standard samples of telm and HCTZ at 
80, 100 and 120 % levels were added to the pre-analysed samples. 
The recovered amounts of telm and HCTZ were calculated at each 
level and % recovery was reported. 
Precision  
The intra-day and inter-day precisions of the proposed 
spectrophotometric method were determined by estimating the 
corresponding response three times on the same day and three 
times on different days over a period of 1 week for 3 different 
concentrations of telm (4.0, 12.0 and 18.0 μg/ml) and HCTZ (8.0, 
12.0 and 16.0 μg/ml). The results were reported in terms of relative 
standard deviation (RSD). Repeatability studies were performed by 
taking the absorbance of single concentration of telm and HCTZ (6 
times). 
LOD and LOQ 
The LOD and LOQ were estimated from the set of 6 calibration 
curves. They were calculated as shown below:  
LOD = 3.3 × (SD/Slope), LOQ = 10 × (SD/Slope) 
Where, SD = Standard deviation of the Y-intercepts of the 6 
calibration curves. 
Slope = Mean slope of the 6 calibration curves. 
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Estimation of Telmisartane and hydrochlorothiazide in the tablet 
Twenty tablets Telista-H each containing telm (40 mg) and HCTZ 
(12.5 mg) were weighed and crushed to fine powder. An accurately 
weighed powder sample equivalent to 40 mg of telm and 12.5 mg 
HCTZ were transferred to a 100 ml conical flasks. These were 
extracted with methanol (4 x 20 ml) and this solution was sonicated 
for 30 min and volume was made up to the mark with methanol in a 
100 mL calibrated volumetric flask, the solution was filtered through 
Whatman filter paper. 2.0 mL of this solution was pipetted out and 
transferred to 100 mL calibrated volumetric flask and volume was 
made up to the mark with methanol to obtain the concentration of 
8µg/ml for telm and 2.5µg/ml for HCTZ. 
These obtained solutions were used for the estimation of telm and 
HCTZ respectively. The responses of the solution were measured 
using first order derivative spectroscopy at the ZCP of telm (251 
nm) for estimation of HCTZ and at the ZCP of Hydrochlorothiazide 
(291 nm) for estimation of telm. The concentration of each drug was 
calculated using an equation of the regression line. 
 
Table 1: Results of recovery study 
Drug Sample concentration 
(µg/ml) 





Telmi 5 4 9 8.8366±0.1021 98.185±1.134 
5 5 10 9.8388±0.055057 98.3666±0.5507 
5 6 11 10.89±0.0264 99±0.2405 
HCTZ 3 2.4 5.4 5.38±0.0122 98.1481±0.1851 
3 3 6 5.89±0.0404 98.2777±0.6735 
3 3.6 6.6 6.4833±0.0305 99.2323±0.4628 
 












4 4.0003±.0.0100 0.2504 3.9966±0.0230 0.5778 
12 1 12.0337±0.0663 0.5512 11.9533±0.0602 0.5042 
18 18.0567±0.0378 0.2096 17.9737±0.0553 0.3077 
HCTZ 8 8.012±0.0081 0.1021 7.9366±0.0503 0.6341 
12 12.0566±0.0585 0.4859 11.8967±0.0602 0.5066 
16 15.99±0.1562 0.9768 15.8400±0.0458 0.2893 
 
RESULTS AND DISCUSSION 
The ZCPs for telm and HCTZ were found to be 251 nm and 291 nm 
respectively. Results of the validation of the above method indicate 
that the method was linear in the range of 2-32µg/ml for telm and 2-
20µg/ml for HCTZ. The data for all validation parameters are 
mentioned in table 1 and 2. The % recoveries for Telmisartan and 
Hydrochlorothiazide obtained in the accuracy study were 98.185-
99.67% and 98.1481-99.232% respectively. The results of the 
precision study indicate that the proposed method showed good 
repeatability for telm and HCTZ with % RSD of 0.592 and 0.8599 
respectively. The % RSD for Intra-day precision was found to be 
0.2504-0.5512 for telm and 0.1021-0.9768 for HCTZ. Similarly % CV 
from the inter-day precision data were found be found to be 0.3077-
0.5778 for telm and 0.2893-0.6028 for HCTZ. The LOD for telm and 
HCTZ as found to be 0.5945 μg/ml and 0.6633 μg/ml respectively. 
Similarly LOQ for telm and HCTZ were found to be 1.801 μg/ml and 
2.0101 μg/ml respectively.  
CONCLUSION 
First order derivative method for simultaneous estimation of telm 
and HCTZ was developed and validated. The method was found to be 
accurate and it is more sensitive even to the minute changes in the 
concentration. It has an advantage that it eliminates the spectral 
interference from one of the two drugs while estimating the other 
drug by selecting zero crossing point in the derivative spectra of 
each drug at the selected wavelength. The % assay results of 99.32% 
for telm and 99.83% for HCTZ indicate that the developed method 
was successfully utilized for the estimation of telm and HCTZ. 
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